Status:
RECRUITING
Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Retinopathy of Prematurity (ROP)
ROP Examination
Eligibility:
All Genders
24-34 years
Brief Summary
The goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that ...
Detailed Description
Imaging studies using HH-SECTR will be performed to assess and quantify structural and vascular disease features associated with ROP. Weekly HH-SECTR imaging will be performed concurrently with standa...
Eligibility Criteria
Inclusion
- Preterm male and female infants born at 24-34 weeks gestational age and weighing \<1500g at birth
Exclusion
- Infants surgically treated for ROP
- Infants with significant health concern that would preclude noninvasive retinal imaging as noted by the primary inpatient team
Key Trial Info
Start Date :
February 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2030
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06612541
Start Date
February 1 2025
End Date
February 1 2030
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232